Company: DVAX
Filing Date: 2025-04-03
Form Type: PREC14A
Source: 0000930413-25-001153
Chunk: 105

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-03
Form: PREC14A
Chunk 105
---
avax, (b) the impact on a director’s independence in the event the related person is a director,
immediate family member of a director or an entity with which a director is affiliated, (c) the terms of the transaction, (d) the availability
of other sources for comparable services or products and (e) the terms available to or from, as the case may be, unrelated third parties
or to or from employees generally. In the event a director has an interest in the proposed transaction, the director must recuse himself
or herself from the deliberations and approval. In determining whether to approve, ratify or reject a related-person transaction, the
Audit Committee considers, in light of known circumstances, whether the transaction is, or is not, consistent with the best interests
of Dynavax and our stockholders, as the Audit Committee determines in the good faith exercise of its discretion.

Indemnity Agreements

We have entered into indemnity agreements with some of our officers
and directors so that they will be free from undue concern about personal liability in connection with their service to the Company. The
indemnity agreements provide, among other things, that the Company will indemnify such officer or director, under the circumstances and
to the extent provided for therein, for expenses, damages, judgments, fines and settlements he or she may be required to pay in actions
or proceedings which he or she is or may be made a party by reason of his or her position as a director, officer or other agent of the
Company, and otherwise to the fullest extent permitted under Delaware law.

| 84 |

<div align='center'>SECURITY OWNERSHIP OF
CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table
sets forth certain information regarding the ownership of the Company’s common stock as of March 14, 2025 by: (i) each director
and nominee for director; (ii) the NEOs; (iii) all executive officers and directors of the Company as a group; and (iv) all those known
by the Company to be beneficial owners of more than five percent of its common stock.

| Name                                                             
 and Address of Beneficial Holder                                 |     |     Number 
         of 
  Shares(2) |     | Percent      
 of Shares    
 Beneficially 
 Owned(3)     |
| 5% Stockholders                                                  |     |            |     |              |
| BlackRock, Inc.(4)                                               |     |